XU Ai-li
XU Ai-li publishes mostly in Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Helicobacter pylori-related gastroenterology studies, Inflammatory Bowel Disease and Pharmacological Effects of Natural Compounds.
- World rank
- #4,885,719 of 7,710,434 ranked researchers
- Rank in China
- #734,039 of 978,568
- Works
- 25
- Citations
- 191
- Citations per work
- 7.6
What does XU Ai-li research?
XU Ai-li's work is mostly in Biochemistry, Genetics and Molecular Biology (18%), Medicine (15%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1455.8%
- Life Sciences623.6%
- Health Sciences414.7%
- Medicine414.7%
- Physical Sciences15.9%
- Engineering15.9%
- 1Molecular Biology12% of their works
- 2Surgery9% of their works
- 3Pulmonary and Respiratory Medicine6% of their works
- 4Control and Systems Engineering6% of their works
- 5Pharmacology6% of their works
- 6Genetics6% of their works
Research topics
- Helicobacter pylori-related gastroenterology studies
- Inflammatory Bowel Disease
- Pharmacological Effects of Natural Compounds
- Bone health and osteoporosis research
- Natural product bioactivities and synthesis
- Bone Metabolism and Diseases
- Computational Drug Discovery Methods
- Industrial Technology and Control Systems
Which keywords describe XU Ai-li's research?
The keywords of their largest research topics: Inflammation, Pathogenesis, Antiviral, Cancer, Gastric Cancer, Helicobacter pylori, Bone Mineral Density and Crohn's Disease.
- Virtual Screening
- Saponins
- Neural Network
- Control System
- Licorice
- Glycyrrhizin
- Crohn's Disease
- Helicobacter pylori
- Cancer
- Pathogenesis
- Inflammation
- Antiviral
- Gastric Cancer
- Bone Mineral Density
- Fractures
- Inflammatory Bowel Disease
- Bone Resorption
- Molecular Docking
- Osteoclast Differentiation
- Triterpenoids
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Inflammation82 topics
- Pathogenesis82 topics
- Antiviral52 topics
- Cancer52 topics
- Gastric Cancer51 topic
- Helicobacter pylori51 topic
- Bone Mineral Density31 topic
- Crohn's Disease31 topic
- Fractures31 topic
- Glycyrrhizin31 topic
- Inflammatory Bowel Disease31 topic
- Licorice31 topic
- Bone Resorption21 topic
- Control System21 topic
- Molecular Docking21 topic
- Neural Network21 topic
- Osteoclast Differentiation21 topic
- Saponins21 topic
- Triterpenoids21 topic
- Virtual Screening21 topic
Where does XU Ai-li work?
XU Ai-li's main affiliation in the publication record is Wangjing Hospital of China Academy of Chinese Medical Sciences, China.
How many publications and citations does XU Ai-li have?
OpenAlex counts 25 works and 191 citations for XU Ai-li, an h-index of 8, ranking #4,885,719 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about XU Ai-li. Posts are plain text and can be reported.